214 related articles for article (PubMed ID: 12892711)
1. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.
Gratton JP; Lin MI; Yu J; Weiss ED; Jiang ZL; Fairchild TA; Iwakiri Y; Groszmann R; Claffey KP; Cheng YC; Sessa WC
Cancer Cell; 2003 Jul; 4(1):31-9. PubMed ID: 12892711
[TBL] [Abstract][Full Text] [Related]
2. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.
Schubert W; Frank PG; Woodman SE; Hyogo H; Cohen DE; Chow CW; Lisanti MP
J Biol Chem; 2002 Oct; 277(42):40091-8. PubMed ID: 12167625
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth.
Lin MI; Yu J; Murata T; Sessa WC
Cancer Res; 2007 Mar; 67(6):2849-56. PubMed ID: 17363608
[TBL] [Abstract][Full Text] [Related]
4. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
Fukumura D; Gohongi T; Kadambi A; Izumi Y; Ang J; Yun CO; Buerk DG; Huang PL; Jain RK
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2604-9. PubMed ID: 11226286
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
6. Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo.
Hatakeyama T; Pappas PJ; Hobson RW; Boric MP; Sessa WC; Durán WN
J Physiol; 2006 Jul; 574(Pt 1):275-81. PubMed ID: 16675496
[TBL] [Abstract][Full Text] [Related]
7. [Effect of nitric oxide derived from endothelial nitric oxide synthase on tumor angiogenesis].
Mei K; Cai XH; Du L; Chen YF; Huang S; Chen J; Yin XD; Zhang ZX; Zhao X; Zhou CY; Yu JR
Chin J Cancer; 2010 Jan; 29(1):32-7. PubMed ID: 20038308
[TBL] [Abstract][Full Text] [Related]
8. Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK.
Jiang Y; Lin X; Tang Z; Lee C; Tian G; Du Y; Yin X; Ren X; Huang L; Ye Z; Chen W; Zhang F; Mi J; Gao Z; Wang S; Chen Q; Xing L; Wang B; Cao Y; Sessa WC; Ju R; Liu Y; Li X
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10737-10742. PubMed ID: 28923916
[TBL] [Abstract][Full Text] [Related]
9. Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.
Morais C; Ebrahem Q; Anand-Apte B; Parat MO
Am J Pathol; 2012 Apr; 180(4):1702-14. PubMed ID: 22322296
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
11. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity.
Predescu D; Predescu S; Shimizu J; Miyawaki-Shimizu K; Malik AB
Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L371-81. PubMed ID: 16093363
[TBL] [Abstract][Full Text] [Related]
12. Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice.
Düwel A; Eleno N; Jerkic M; Arevalo M; Bolaños JP; Bernabeu C; López-Novoa JM
Tumour Biol; 2007; 28(1):1-8. PubMed ID: 17108712
[TBL] [Abstract][Full Text] [Related]
13. VEGF-induced permeability increase is mediated by caveolae.
Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
[TBL] [Abstract][Full Text] [Related]
14. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy.
Sonveaux P; Brouet A; Havaux X; Grégoire V; Dessy C; Balligand JL; Feron O
Cancer Res; 2003 Mar; 63(5):1012-9. PubMed ID: 12615716
[TBL] [Abstract][Full Text] [Related]
15. S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability.
Marín N; Zamorano P; Carrasco R; Mujica P; González FG; Quezada C; Meininger CJ; Boric MP; Durán WN; Sánchez FA
Circ Res; 2012 Aug; 111(5):553-63. PubMed ID: 22777005
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis.
Zhao X; Lu X; Feng Q
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2371-8. PubMed ID: 12388304
[TBL] [Abstract][Full Text] [Related]
17. Endothelial NO synthase and reactive oxygen species mediated effect of simvastatin on vessel structure and function: pleiotropic and dose-dependent effect on tumor vascular stabilization.
Chen Y; Zhang S; Peng G; Yu J; Liu T; Meng R; Li Z; Zhao Y; Wu G
Int J Oncol; 2013 Apr; 42(4):1325-36. PubMed ID: 23426387
[TBL] [Abstract][Full Text] [Related]
18. An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide.
Scotland RS; Chauhan S; Vallance PJ; Ahluwalia A
Hypertension; 2001 Oct; 38(4):833-9. PubMed ID: 11641295
[TBL] [Abstract][Full Text] [Related]
19. Caveolin, caveolae, and endothelial cell function.
Frank PG; Woodman SE; Park DS; Lisanti MP
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1161-8. PubMed ID: 12689915
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
